Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Validation Study of Early Cancer Biomarkers in Breath Condensate of Individuals With High-Risk of Lung Cancer Undergoing Low-Dose Computer Tomography Based Screening.

NCT06016569 is registered in ClinicalTrials.gov with The Institute of Molecular and Translational Medicine, Czech Republic as lead sponsor.

NCT NCT06016569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06016569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Validation Study of Early Cancer Biomarkers in Breath Condensate of Individuals With High-Risk of Lung Cancer Undergoing Low-Dose Computer Tomography Based Screening.
Lead sponsor
The Institute of Molecular and Translational Medicine, Czech Republic
Phase
Not applicable
Overall status
Recruiting
Start date
June 1, 2023
Completion date
December 31, 2030
Enrollment
3,200 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer